0 CHECKOUT

PRODUCT FILTERS

REGION

46
27
23
23
23

COUNTRY

23
1
1

CATEGORIES

  • 35
  • 31
  • 16
  • 16
  • 14
  • 12
  • 10
  • 9
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

8
46
65
167

PUBLISHED

2
22
62
167

PRODUCT TYPE

151
7
7
2

Search for: "Company Analysis - Biocon Limited"

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring...

Published:  December 2015
Price:  From

Biocon Limited (532523) - Financial and Strategic SWOT Analysis Review

Biocon Limited (532523) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a fully integrated healthcare company engaged in the manufacturing of biopharmaceutical products...

Published:  April 2011
Price:  From

Biocon Limited - Product Pipeline Review - 2015

Biocon Limited - Product Pipeline Review - 2015 Summary The report ‘Biocon Limited - Product Pipeline Review - 2015’, provides an overview of the Biocon Limited’s pharmaceutical research and development...

Published:  August 2015
Price:  From

BIOCON Limited Acquisition Manual

The Acquisition Manual on BIOCON Limited is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all aspects of Biocon so that...

Published:  February 2016
Price: 

Biocon Limited - Product Pipeline Review - H2 2011

Biocon Limited – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - H2 2011” provides data on the Biocon Limited’s...

Published:  November 2011
Price:  From

Biocon Limited - Product Pipeline Review - Q4 2010

Biocon Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Biocon Limited - Product Pipeline Review - Q4 2010

Biocon Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Pharmaceuticals Manufacturing Industry in India 2015 - 2020

Pharmaceuticals Manufacturing Industry in India is expected to be worth US$ 41.92 billion by 2020. Indian pharmaceuticals manufacturing market is expected to grow at a CAGR of 19.76% by 2020. This...

Published:  August 2015
Price:  From

Pharmaceuticals Industry in India 2015-2020

Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population,...

Published:  August 2015
Price:  From

Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices. In depth market scenario includes: - Indian Biopharmaceuticals...

Published:  March 2015
Price: 

Biocon Limited

A textual analysis of the financial results for Biocon Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

Published:  July 2015
Price:  From

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

Published:  August 2012
Price:  From

Biotechnology in India - Global Business Strategic Report

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual...

Published:  May 2012
Price:  From

Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth

GBI Research, the leading business intelligence provider, has released its latest research “Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding...

Published:  January 2013
Price:  From

Opportunity in Biotechnology Industry in India - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Opportunity in Biotechnology Industry current scenario, structure and practices in India. In depth market scenario includes; - Current market size estimates -...

Published:  January 2015
Price: 

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Indian Anti-Diabetic Pharmaceuticals current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate -...

Published:  March 2015
Price: 

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F)

'India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key...

Published:  December 2015
Price:  From

Indian Generic Drug Market Outlook 2020

Generics drugs are bioequivalent versions of the originator medicines. These drugs are cheaper and offer similar health benefits as those of branded counterparts. Generics are showing high penetration...

Published:  September 2015
Price:  From

Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020

Diabetes refers to a group of metabolic disease characterized by high blood sugar level. It occurs due to inadequate secretion of insulin inside the pancreas. Some of the common symptoms for diabetes...

Published:  February 2015
Price:  From

Global Biosimilars: A return to optimism?

A Critical Strategic Analysis from Espicom Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies – and some surprising names – are positioning...

Published:  January 2012
Price:  From
Loading Indicator

Our Clients

  • Ikea Systems B.V.
  • GlaxoSmithKline PLC
  • BT Group PLC.
  • Philips N.V.
  • BSH Home Appliances Ltd
  • Foreign & Commonwealth Office